REDHILL BIOPHARMA LTD. (RDHL) Revenue 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$8.0MFY2024 · since FY2015: $3,000 → $8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $8.0M | +23.2% |
| FY2023 | $6.5M | -89.4% |
| FY2022 | $61.8M | -27.9% |
| FY2021 | $85.8M | +33.2% |
| FY2020 | $64.4M | +923.0% |
| FY2019 | $6.3M | -24.7% |
| FY2018 | $8.4M | +108.6% |
| FY2017 | $4.0M | +3867.3% |
| FY2016 | $101,000 | +3266.7% |
| FY2015 | $3,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →